HHS plans two new deputy commissioners at FDA, CNBC reports

The U.S. Department of Health and Human Services (HHS) is set to appoint two new deputy commissioners at the Food and Drug Administration (FDA), according to CNBC. The report, based on sources familiar with the matter, suggests that one role will concentrate on technology, encompassing healthcare and artificial intelligence. The other position would oversee drug regulation.

The agency has not publicly announced the appointments, and final decisions have yet to be made. Jared Seehafer is the leading contender for the technology role, as per three sources familiar with the plans. The candidate for the deputy commissioner position overseeing drugs has not been disclosed by the report. President Donald Trump recently appointed White House policy aide Heidi Overton to lead the FDA, though her nomination still requires confirmation by the U.S. Senate.